The TGA regulates therapeutic goods, but a TGA or ARTG reference does not decide whether a particular option is suitable for one person or whether a practitioner is competent. A patient can ask which good is proposed after assessment, whether it is included in the Australian Register of Therapeutic Goods or accessed through another lawful pathway, how the clinic verifies its source, identity, expiry and storage requirements, and what record supports recall or adverse event follow up. Some unapproved goods can be supplied lawfully through specific access pathways, so absence from the ARTG is a question requiring explanation rather than automatic proof of illegal supply.
First Separate The Good, The Practitioner And The Clinic
Three different questions are often compressed into “Is this TGA approved?” The first concerns the therapeutic good and its lawful supply. The second concerns the registration, scope and conduct of the practitioner. The third concerns the clinic’s consent, records, storage, infection control and follow up systems.
The TGA regulates therapeutic goods. Ahpra and National Boards regulate registered health practitioners. State and territory bodies may handle health service complaints. One regulator’s role should not be used as proof that every other part of the chain is sound.
Follow The Five Links In Order
| Link | Patient question | Useful answer |
|---|---|---|
| 1. Status | Is it in the ARTG, or which lawful pathway applies? | The specific status after assessment. |
| 2. Source | How did the clinic obtain it? | An authorised, traceable route. |
| 3. Identity | How is the item linked to my record? | Name, batch or lot and expiry where applicable. |
| 4. Handling | How are storage requirements followed? | A monitored process and records. |
| 5. Response | What happens after a defect, recall or suspected adverse event? | A contact, traceable record and reporting route. |
What Does The ARTG Establish?
The Australian Register of Therapeutic Goods is the public database of goods that can be supplied in Australia. Search results can include the product name, formulation details, sponsor, manufacturer and supporting public documents where available.
An ARTG entry is regulatory evidence about a therapeutic good. It is not a personal recommendation, proof that a particular use fits the person in front of the practitioner, or evidence that the clinic stored and handled the item correctly.
Why Can A Missing ARTG Entry Need More Explanation?
The TGA describes goods not included in the ARTG as unapproved therapeutic goods. It also provides limited pathways through which certain registered health practitioners may lawfully access unapproved goods, including the Special Access Scheme, Authorised Prescriber pathway and clinical trials.
Unapproved does not automatically mean unlawfully supplied, unsafe or ineffective. It does mean the TGA has not evaluated that good through the ordinary ARTG route for quality, safety or effectiveness. A patient should be told that status and the relevant implications as part of an individual decision.
Why Might A Public Website Avoid Product Names?
Some therapeutic goods cannot lawfully be advertised to the public. TGA guidance says prescription medicines and unapproved therapeutic goods are among the categories prohibited from public advertising. Direct names, nicknames, indirect descriptions, links and promotional effects can all matter.
That means absence of a product menu on a public clinic page can reflect advertising compliance rather than secrecy. After assessment, the private consent conversation can still explain the specific proposed good, alternatives, material risks and relevant regulatory status.
What Can A Patient Ask About Supply?
Ask whether the clinic uses an authorised Australian supply route and whether the item can be traced to the relevant supplier or sponsor record. Do not rely on an apparently sealed box, a social media photograph or a statement that the item is “genuine”.
The useful answer is a clinic system: receipt and stock records, identity and expiry checks, separation of unsuitable stock, and a way to identify affected patients if a defect or recall is announced. The exact records required can depend on the type of good and applicable law.
How Should Storage Integrity Be Discussed?
Storage is not one universal temperature. The clinic should follow the manufacturer’s approved instructions and any applicable professional, legal and facility requirements for that good. A patient does not need to inspect a back room to ask whether the process is monitored and documented.
Useful questions include who checks storage conditions, how a deviation is recognised, what happens to stock after a suspected excursion, and how expiry and opening dates are controlled where relevant. “It stays in the fridge” is not a complete answer when the actual requirements and records are never addressed.
Which Details Belong In The Patient Record?
The record should be sufficient to reconstruct what was proposed and, if care proceeds, what was supplied or administered. Depending on the good and context, relevant details can include the name, dose or amount, site, date, batch or lot, expiry, supplier or prescriber information and the people involved.
This page does not prescribe a universal record template. The practical test is whether the clinic could identify the exact patient and affected stock if a defect, recall, complaint or adverse event needed investigation.
What Does TGA Regulation Not Prove?
- that a person is suitable for a cosmetic procedure
- that a practitioner has the necessary competence or scope
- that consent was voluntary and sufficiently informed
- that the item was sourced, stored and handled correctly at this clinic
- that an expected appearance change will occur
- that every adverse event was caused by the therapeutic good
Regulation narrows uncertainty; it does not remove clinical judgement, system responsibility or individual variation.
What If A Clinic Uses “TGA Approved” As The Whole Answer?
Ask for the exact ARTG entry or lawful access explanation relevant to the proposed good, then continue down the chain. Who supplied it? How is the item identified in the record? Which storage instructions apply? How would the clinic respond to a recall?
A broad badge can be accurate but incomplete. The patient needs enough information to understand the proposed care, not a slogan used to end the conversation.
How Are Defects, Recalls And Adverse Events Different?
A product defect can concern manufacture, packaging, storage or handling. A recall or other market action is a coordinated response to a product issue. An adverse event is a suspected harmful or unintended problem associated with a therapeutic good, but its occurrence does not by itself prove the good caused it.
The TGA accepts reports about adverse events and safety problems. Urgent symptoms still require appropriate clinical care first. Reporting to a regulator is not a substitute for emergency assessment or the clinic’s immediate review responsibilities.
Use The Six Line Consultation Note
- Proposed good: the specific identity explained privately after assessment.
- Status: ARTG entry or lawful access pathway.
- Source: authorised supply route and traceability.
- Record: identity, expiry, batch or lot and administration details where relevant.
- Handling: applicable storage instructions and response to a deviation.
- Problem route: clinic contact, urgent care boundary, recall process and TGA report pathway.
If one line remains blank, ask for clarification before making the decision.
How Does Core Aesthetics Answer The Chain?
Core Aesthetics identifies Corey Anderson as a Registered Nurse with Ahpra registration NMW0001047575. The clinic operates in Oakleigh and publishes a direct contact route in the site details.
Specific therapeutic good information is discussed privately when it is relevant to an assessed adult rather than promoted on this page. A patient may ask Corey to explain the regulatory status or access pathway, supply traceability, applicable storage system, patient record and problem route before deciding. Timing or another clinically appropriate pathway remains available.
Which Page Answers The Advertising Question?
This page owns product status, supply integrity, storage records and safety reporting. Use the TGA cosmetic advertising guide when the question is whether website language, images, links or promotions may advertise a therapeutic good.
Use the regulation and scope guide when the question is which regulator oversees the practitioner, product, service or advertising issue.
Which Official Sources Support This Guide?
- TGA: About the Australian Register of Therapeutic Goods
- TGA: Product regulation according to risk
- TGA: Access unapproved products for consumers
- TGA: What can and cannot be advertised to the public
- TGA: Report a problem with a therapeutic good
- TGA: Report an adverse event or safety problem
- Ahpra public register
Sources were checked on 16 July 2026. They explain the regulatory framework and public reporting routes; they do not establish the status, suitability or legality of a specific item without its identifying information and context.
Questions About TGA Product Regulation
What is the ARTG?
The Australian Register of Therapeutic Goods is the public database of goods that can be supplied in Australia. It can show product, sponsor, manufacturer and supporting information. An entry does not decide whether that good is suitable for one person or prove how a clinic handled it.
Does no ARTG entry always mean illegal supply?
No. The TGA permits limited lawful access to certain unapproved goods through pathways such as the Special Access Scheme, Authorised Prescriber pathway and clinical trials. The relevant practitioner should explain the status, access route and implications in the individual consent discussion.
Why does this page not name cosmetic prescription products?
TGA rules prohibit public advertising of prescription medicines and unapproved therapeutic goods. Product names, nicknames, indirect references, links and promotional effects can matter. Specific information can be discussed privately after assessment when it is relevant to informed consent.
What does TGA regulation not prove?
It does not prove personal suitability, practitioner competence, adequate consent, correct clinic storage, a particular outcome or that a later symptom was caused by the good. Product regulation, practitioner regulation and clinic systems answer different parts of the safety question.
How can I ask about product storage without inspecting the clinic?
Ask which manufacturer storage instructions apply, who monitors them, how deviations are identified, what happens to affected stock and how expiry or opening dates are controlled where relevant. A documented process is more meaningful than a photograph of a cupboard or refrigerator.
Which product details may matter in my clinical record?
Depending on the good and context, useful traceability details can include the name, dose or amount, site, date, batch or lot, expiry, supplier or prescriber information and people involved. The record should support review, recall, defect and adverse event investigation.
Is a TGA logo or “approved” statement enough?
No. Ask for the relevant ARTG entry or lawful access explanation, then check supply source, identity, handling, record and problem response. A broad regulatory statement may be accurate but still incomplete for an individual decision.
What is the difference between a defect and an adverse event?
A defect concerns the product or its manufacture, packaging, storage or handling. An adverse event is a suspected harmful or unintended problem associated with a therapeutic good. An adverse event does not automatically prove that the good caused the problem.
Can a consumer report a suspected adverse event to the TGA?
Yes. The TGA accepts consumer and health professional reports about adverse events and safety problems. Seek appropriate clinical or emergency care first when symptoms are urgent. A regulatory report does not replace assessment or the clinic’s immediate review pathway.
Who regulates the practitioner rather than the product?
Ahpra and the relevant National Board regulate registered health practitioners. The TGA regulates therapeutic goods and their advertising. State or territory bodies may handle health service complaints. Use the official route matching the product, practitioner, service or advertising concern.
Is this for you?
Consider booking a consultation if
- Adults who want to understand an ARTG entry or lawful access explanation
- Patients asking about authorised supply, storage, traceability and recall records
- Readers separating product regulation from practitioner and clinic accountability
- People preparing factual questions before an individual consent decision
This may not be for you if
- Anyone seeking public promotion or comparison of prescription medicines
- People treating TGA status as proof of personal suitability
- Anyone using a regulatory report instead of urgent health care
- People seeking a legal finding about a specific clinic or product without identifying evidence
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Clinical references
- About the Australian Register of Therapeutic Goods
- Product regulation according to risk
- Access unapproved products for consumers
- What can and cannot be advertised to the general public
- Report a problem with a therapeutic good
- Report an adverse event or safety problem
- Ahpra public register of practitioners